Skip to content

Traditional Chinese medicine as a new treatment for surgical site infection in patients with cesarean delivery: a randomized controlled trial

Traditional Chinese medicine as a new treatment for surgical site infection in patients with cesarean delivery: a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005436
Enrollment
Unknown
Registered
2021-12-22
Start date
2018-12-31
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

surgical site infection in patients with cesarean delivery

Interventions

2:external application of TCM

Sponsors

Ningbo Women and Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
21 Years to 37 Years

Inclusion criteria

Inclusion criteria: (1) single and term pregnancies, (2) failed vaginal labor (OS 10 cm), and (4) CD performed due to fetal head descent.

Exclusion criteria

Exclusion criteria: The exclusion criteria were as follows: (1) gestational diabetes mellitus (GDM) or (2) hypertension or other complications. All participants provided written informed consent.

Design outcomes

Primary

MeasureTime frame
SSI;

Countries

Chian

Contacts

Public ContactGuanya Han
hanguanya@sina.cn13732154652

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026